1<p>These values compare the strategy to the one directly above it on the table.</p><p>Cost-Effectiveness of Treatment Strategies for <i>BRAF - Table 3 </i>-Mutated Metastatic Melanoma</p
ObjectiveTo determine whether a next-generation sequencing (NGS) panel of 34 cancer-associated genes...
ObjectiveTo determine whether a next-generation sequencing (NGS) panel of 34 cancer-associated genes...
The Author(s) 2015. This article is published with open access at Springerlink.com Objective To dete...
1<p>These values compare the strategy to the one directly above it on the table.</p><p>Cost-Effectiv...
<p>PET = positron emission tomography. CT = computed tomography. SCC = squamous cell carcinoma. SE =...
<p>Source numbers reflect the corresponding citation in the references section of this article. A so...
© 2014 Curl et al.Purpose: Genetically-targeted therapies are both promising and costly advances in ...
Purpose: Genetically-targeted therapies are both promising and costly advances in the field of oncol...
PURPOSE:Genetically-targeted therapies are both promising and costly advances in the field of oncolo...
International audienceNine drugs have been marketed for 10 years for the treatment of advanced melan...
Purpose. Two BRAFV600E targeted therapies, dabrafenib and vemurafenib, have received US approval for...
gene have been approved. They extend life but are more expensive than the previous standard of care...
gene have been approved. They extend life but are more expensive than the previous standard of care...
Background: The treatment of patients with metastatic melanomas that harbour BRAF V600E or V600K mut...
Copyright © 2015 Vanessa Shih et al. This is an open access article distributed under the Creative C...
ObjectiveTo determine whether a next-generation sequencing (NGS) panel of 34 cancer-associated genes...
ObjectiveTo determine whether a next-generation sequencing (NGS) panel of 34 cancer-associated genes...
The Author(s) 2015. This article is published with open access at Springerlink.com Objective To dete...
1<p>These values compare the strategy to the one directly above it on the table.</p><p>Cost-Effectiv...
<p>PET = positron emission tomography. CT = computed tomography. SCC = squamous cell carcinoma. SE =...
<p>Source numbers reflect the corresponding citation in the references section of this article. A so...
© 2014 Curl et al.Purpose: Genetically-targeted therapies are both promising and costly advances in ...
Purpose: Genetically-targeted therapies are both promising and costly advances in the field of oncol...
PURPOSE:Genetically-targeted therapies are both promising and costly advances in the field of oncolo...
International audienceNine drugs have been marketed for 10 years for the treatment of advanced melan...
Purpose. Two BRAFV600E targeted therapies, dabrafenib and vemurafenib, have received US approval for...
gene have been approved. They extend life but are more expensive than the previous standard of care...
gene have been approved. They extend life but are more expensive than the previous standard of care...
Background: The treatment of patients with metastatic melanomas that harbour BRAF V600E or V600K mut...
Copyright © 2015 Vanessa Shih et al. This is an open access article distributed under the Creative C...
ObjectiveTo determine whether a next-generation sequencing (NGS) panel of 34 cancer-associated genes...
ObjectiveTo determine whether a next-generation sequencing (NGS) panel of 34 cancer-associated genes...
The Author(s) 2015. This article is published with open access at Springerlink.com Objective To dete...
DOI
Add to ORKG